Inspire Medical Systems opened lower at $62.00, compared with its previous close of $62.11. In the last trading session, the stock traded between $60.39 and $62.54. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Inspire Medical Systems is now worth
$ 22.07
Resulting in a loss of
$ 77.93 (77.93%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 13 Analysts
Buy
30.77%
Hold
53.85%
Sell
15.38%
Markets Today
Today's Change
$-1.59 (-2.56%)
Day High
$62.54
Day Low
$60.39
Day Open
$62.00
Prev Close
$62.11
Volume
4,24,168
1W Return
-9.02%
1M Return
-15.24%
3M Return
2.23%
6M Return
39.60%
1Y Return
-33.20%
Fundamentals
Market Cap ($ Mn)
1,753
PE Ratio
13.53
PB Ratio
2.15
PEG Ratio
0.08
ROE
21.07%
ROCE
6.70%
EPS (TTM)
$-0.84
Investment Returns
1 Week
-9.02%
1 Month
-15.24%
3 Months
2.23%
6 Months
39.60%
9 Months
-11.28%
Financials
Quarterly
All values in $ Mn
217.1
Jun 25
224.5
Sep 25
269.1
Dec 25
204.6
Mar 26
200.6
Jun 26
206.7
Sep 26
Updates
4Nov
JP Morgan raises Inspire Medical price target to $65, keeps neutral rating
JP Morgan maintains Neutral rating on Inspire Medical Systems. Price target raised to $65 from $60 by analyst Robbie Marcus. Rating unchanged despite increase in price target.
9 days ago
4Nov
Truist Securities cuts Inspire Medical price target to $76, keeps Hold
Truist Securities reiterated a Hold rating on Inspire Medical Systems. Price target reduced from $78 to $76. Analyst Richard Newitter maintained a neutral stance on the stock.
9 days ago
3Nov
Wells Fargo raises Inspire Medical Systems price target to $69
Wells Fargo raised Inspire Medical Systems' price target from $56 to $69. Analyst Larry Biegelsen maintained an Equal-Weight rating on the stock. The revision reflects an updated valuation perspective for the company.
9 days ago
3Nov
Barclays lowers Inspire Medical price target to $62, maintains underweight
Barclays maintains an Underweight rating on Inspire Medical Systems. Price target lowered from $65 to $62. Analyst Christopher Pasquale issued the rating update.
9 days ago
3Nov
Piper Sandler raises Inspire Medical Systems price target to $70
Piper Sandler raised Inspire Medical Systems' price target to $70. Previous price target was set at $60. Analyst Adam Maeder maintains a Neutral rating.
9 days ago
3Nov
Inspire Medical Systems Q3FY26 Results: EPS beats by 56%, revenue down 8%
Inspire Medical Systems reported Q3 adjusted EPS of $0.14, beating estimates by 55.56%. Quarterly revenue fell 7.93% YoY to $206.695 million but exceeded consensus estimates. FY2026 GAAP EPS guidance narrowed to $(0.36)-$(0.10) from previous $(0.42)-$0.17. Adjusted operating income declined 82.6% YoY due to restructuring and legal charges.
